An analysis by the consultancy Baringa found that individuals need almost £100,000 in discretionary income per year to realize savings on grocery bills after spending £1,200 annually on GLP‑1 weight‑loss medication.

The high price of GLP‑1 drugs means the outlay exceeds any reduction in food expenses for most consumers, creating a disproportionate financial impact.

The study examined household spending patterns and concluded that only the highest earners achieve overall savings, while the majority see no net benefit.

Further research is required to determine how widespread use of the medication will affect household budgets and long‑term economic outcomes.